The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...

Start the conversation: Use the Wix AI chat to describe your site. Go over your site checklist: Follow the steps, use Wix ...

In a chemistry lab at Western Reserve Academy, the former model was badly burned on almost half of her body. Today, she's ...

YUVEZZI (TM) (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is a dual-agent eye drop approved by the U.S. Food & Drug Administration (FDA) for the treatment of presbyopia, a ...

The FDA has approved the first dual-agent eye drop to treat presbyopia, a condition that causes gradual loss of near vision in adults.

Q2 2026 Earnings Call February 1, 2026 7:30 PM ESTCompany ParticipantsMark Flynn - Investor RelationsThomas Spurling - ...

Immunology biotech Agomab Therapeutics and eye-focused SpyGlass Pharma have both unveiled their intentions to go public in the latest sign the IPO window is reopening in 2026. Neither company has set ...

Bring on the pigment.

LEDGEWOOD, N.J. (PIX11) — A company claiming to be “America’s Largest Ophthalmic Pharmacy” has issued a recall for multiple eye drop products for the presence of glass-like particles, according to the ...

A grammy-winning singer has requested to be dropped from her music label Republic Records, citing lack of support for her ...

Tenpoint Therapeutics’ Yuvezzi brings a combination approach to presbyopia compared to single mechanisms of action offered by once-daily eye drops from Orasis Pharmaceuticals, Lenz Therapeutics, and ...

Gov. Tim Walz (D-MN) is dropping his reelection bid for a third term as Minnesota governor, he announced on Monday, saying he cannot simultaneously wage a political campaign while confronting what he ...